Chester County News and Community Website
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced a significant milestone in cancer treatment. The company recently dosed the first patient in its Phase 1 clinical trial of …
Carisma Therapeutics Launches First Human Trial for CAR-Monocyte Therapy Read More
BERWYN, PA — Mural Health has been awarded the title of “Most Innovative Start-up” at the 2024 Citeline Awards. Citeline, a leader in business intelligence for pharmaceutical and medtech markets, …
Mural Health Named ‘Most Innovative Start-up’ at 2024 Citeline Awards Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focusing on innovative therapies, announced the completion of dosing in the second cohort of its groundbreaking GARDian clinical trial for …
Ocugen Advances with Phase 1/2 Trial for Stargardt Disease Treatment Read More
RADNOR, PA — NRx Pharmaceuticals (Nasdaq: NRXP) recently highlighted a compelling advantage in safety for its drug NRX-101, in comparison to the standard treatments offered in its latest clinical trial. …
NRx Pharmaceuticals Makes Significant Stride with New Depression Drug, Aims for Accelerated FDA Approval Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) announced this week new research findings that highlight the benefits of the Prostatic Urethral Lift (PUL) using the UroLift™ System for benign prostatic …
New Research Sheds Light on Superior Patient Experience with UroLift System in Prostate Treatment Read More
NEWTOWN, PA — Traws Pharma, Inc. announced this week the completion of dosing in the first cohort of a groundbreaking Phase 1 study on travatrelvir (TRX01), an innovative oral protease …
Traws Pharma Advances COVID-19 Treatment into First Human Trials Read More
WAYNE, PA — XyloCor Therapeutics, Inc. recently revealed the final results from the Phase 2 segment of its EXACT clinical trial at the Society for Cardiovascular Angiography & Interventions (SCAI) …
XyloCor Therapeutics Announces Promising Results for Gene Therapy in Treating Refractory Angina Read More
BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) has unveiled hopeful results from its Maximum Tolerated Dose (MTD) study of Probudur™, a long-acting pain management drug, in Sprague-Dawley rats. Probudur, …
Virpax Pharmaceuticals’ Probudur Shows Promising Results in Pain Management Study Read More RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) disclosed encouraging preliminary outcomes from a study on NRX-101, an investigational drug designated as a breakthrough therapy. The drug demonstrated a promising, …
NRx Pharmaceuticals Breakthrough Drug Shows Potential to Reduce Suicide Risk in Bipolar Depression Patients Read More
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has received approval from the U.S. Food and Drug Administration (FDA) to commence a Phase 1 clinical trial for CTIM-76, a pioneering …
FDA Clears Context Therapeutics to Begin Trial for Novel Cancer Therapy Read More